Skip to content
VendorVerify

ACR Aavant

#5 of 30 ranked

Vials tend to hold more than the label (median +9.4%); 0 of 41 vials were more than 10% under.

VendorVerify score90.3
Above marketMarket average 86.4
0.0%of vials failed (0 of 45)

For research use only. VendorVerify sells nothing and takes no money from vendors. No affiliate links, no coupon codes, no paid rankings. How scores work

Every vial we have on file

  • Within ±5% / purity 99%+
  • 5–20% under, overfilled / purity 95–99%
  • Failed: over 20% under, over 50% over, empty or under 95% pure

Dose vs label

41 vials measured · 0 empty

Purity

45 vials measured
Median purity
99.68%
across 45 vials
Median dose vs label
+9.4%
across 41 vials; + means more than the label
Failed vials
0.0%
0 of 45 vials; the rate weights each lab report equally and recent reports more, as the score does
Lab reports
17
Mar 14, 2025 to Feb 16, 2026

Labs: Janoshik, Peptide Test

Key facts

  • VendorVerify holds third-party lab results for 45 ACR vials from 17 lab reports, dated Mar 2025 to Feb 2026.
  • 1 of those ACR lab reports was commissioned by ACR itself and count at half weight in the score.
  • 0 of 45 ACR vials failed: empty, under 95% pure, more than 20% under the label or more than 50% over it.
  • The median ACR vial tested at 99.68% purity across 45 vials with a purity result.
  • The median ACR vial held +9.4% compared with its label across 41 vials where the lab measured the amount.
  • Buyers have had 3 different compounds from ACR lab tested.
  • ACR ranks #5 of 30 ranked vendors on the VendorVerify score.
  • ACR vials on file were tested by Janoshik, Peptide Test.

By peptide

PeptideVialsFailedMedian purityMedian dose vs labelDose vs label, −20% to +20%
Tirzepatide28099.68%+9.6%
Retatrutide12099.69%+7.0%
KPV5098.90%+5.6%

Lab reports

One row per tested vial, newest first. Tests marked vendor-commissioned were paid for by ACR; they count at half weight in the score and don't count toward ranking.

DatePeptideLabLabelMeasuredDose vs labelPurity
Feb 16, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)Janoshik12 mg13.51 mg+12.6%99.15%
Feb 16, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)Janoshik12 mg13.59 mg+13.2%99.18%
Feb 16, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)Janoshik12 mg13.52 mg+12.7%99.13%
Jan 23, 2026TirzepatideBatch 967288-000002Janoshik60 mg58.21 mg−3.0%99.91%
Jan 5, 2026KPVBatch 967289-00001 (Clear lavendar cap)Janoshik15 mg15.56 mg+3.7%98.85%
Jan 5, 2026KPVBatch 967289-00001 (Clear lavendar cap)Janoshik15 mg15.84 mg+5.6%98.90%
Jan 5, 2026KPVBatch 967289-00001 (Clear lavendar cap)Janoshik15 mg15.44 mg+2.9%98.61%
Dec 23, 2025RetatrutideBatch r11 Batch 3Janoshik—10.66 mg—99.69%
Nov 24, 2025KPVBatch 967289-000001 (purple cap)Vendor-commissionedJanoshik15 mg17 mg+13.3%99.68%
Nov 24, 2025KPVBatch 967289-000001 (purple cap)Vendor-commissionedJanoshik15 mg17.11 mg+14.1%99.75%

Other lab tests

Endotoxin, TFA, counterion and contaminant checks, as reported by the lab. They are shown for transparency and are not part of the score.

DatePeptideTestResultLab
Feb 24, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)SterilityTAMC=Pass, TYMC=PassJanoshik
Feb 16, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)LCMSMannitol, retatrutide, and degradation products; no significant contaminationJanoshik
Feb 13, 2026RetatrutideBatch 967286-000004 (vendor inferred from batch code; report lists manufacturer as Unknown)Endotoxin<10 EU/Vial (1.641 EU/Vial estimate)Janoshik
Feb 6, 2026TirzepatideBatch 967288-000002SterilityTAMC=Pass, TYMC=PassJanoshik
Jan 30, 2026KPVBatch 967289-0001SterilityTAMC=Pass, TYMC=PassJanoshik
Jan 29, 2026TirzepatideBatch 967288-000002Heavy MetalsNot detected (As, Cd, Pb)Janoshik
Jan 26, 2026TirzepatideBatch 967288-000002Endotoxin>10 EU/Vial (15.135 EU/Vial estimate)Janoshik
Jan 26, 2026TirzepatideBatch 967288-000002TFANot detectedJanoshik
Jan 22, 2026TirzepatideBatch 967288-000002LCMSMannitol, tirzepatide, and degradation productsJanoshik
Jan 20, 2026RetatrutideBatch 967285-000005SterilityTAMC=Pass, TYMC=PassJanoshik

ACR: common questions

Is ACR legit?

We can't vouch for any vendor as a business, and we don't sell or recommend products. What we can show is what buyers' independent lab tests found: 0 of 45 ACR vials on file failed, meaning they were empty, under 95% pure, more than 20% under the label or more than 50% over it. That places ACR #5 of 30 ranked vendors, above market on our score. Results on file run from Mar 2025 to Feb 2026.

Has ACR been third-party tested?

Yes. We hold results for 45 ACR vials from 17 lab reports, tested by Janoshik, Peptide Test. 16 of those reports were paid for by buyers or group tests; 1 was commissioned by ACR itself, verified at the lab, and count at half weight in the score.

Are ACR vials dosed correctly?

Across 41 vials where the lab measured the amount, the median ACR vial held +9.4% compared with its label. 0 of 41 held more than 10% less than the label said.

How pure is ACR?

The median ACR vial tested at 99.68% purity across 45 vials with a purity result. We count anything under 95% as a failed vial, and a vial at 99.5% or higher gets full marks for purity.

Does ACR pay to be listed or ranked?

No. VendorVerify sells nothing and takes no money from vendors. No affiliate links, no coupon codes, no paid rankings. A vendor's place comes only from lab results.

Will my ACR vial match these results?

Not necessarily. A lab report describes the vials that were tested, and batches differ. A clean record lowers the odds of a bad vial but doesn't rule one out, which is why newer reports count for more in the score.

Vendor Reviews

Bought from this vendor?

Sign in to write a review. Every review comes from a verified phone number and a real purchase.